NO20065768L - Karbonsamid-opioidforbindelser - Google Patents
Karbonsamid-opioidforbindelserInfo
- Publication number
- NO20065768L NO20065768L NO20065768A NO20065768A NO20065768L NO 20065768 L NO20065768 L NO 20065768L NO 20065768 A NO20065768 A NO 20065768A NO 20065768 A NO20065768 A NO 20065768A NO 20065768 L NO20065768 L NO 20065768L
- Authority
- NO
- Norway
- Prior art keywords
- opioidforbindelser
- karbonsamid
- nervous system
- central nervous
- carboxamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/38—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to a carbon atom of a ring other than a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57129804P | 2004-05-14 | 2004-05-14 | |
PCT/US2005/016581 WO2005113486A1 (en) | 2004-05-14 | 2005-05-11 | Carboxamido opioid compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065768L true NO20065768L (no) | 2007-02-07 |
Family
ID=35064532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065768A NO20065768L (no) | 2004-05-14 | 2006-12-14 | Karbonsamid-opioidforbindelser |
Country Status (22)
Country | Link |
---|---|
US (2) | US7244866B2 (ja) |
EP (1) | EP1748978B1 (ja) |
JP (1) | JP5420170B2 (ja) |
KR (1) | KR101204751B1 (ja) |
CN (1) | CN1984879B (ja) |
AR (1) | AR049276A1 (ja) |
AU (1) | AU2005245403B2 (ja) |
BR (1) | BRPI0511137A (ja) |
CA (1) | CA2566601C (ja) |
CR (1) | CR8811A (ja) |
EA (1) | EA013261B1 (ja) |
EC (1) | ECSP067008A (ja) |
ES (1) | ES2485867T3 (ja) |
HK (1) | HK1101246A1 (ja) |
IL (1) | IL179196A (ja) |
MX (1) | MXPA06013270A (ja) |
NO (1) | NO20065768L (ja) |
NZ (1) | NZ551288A (ja) |
TW (1) | TWI418345B (ja) |
UA (1) | UA90432C2 (ja) |
WO (1) | WO2005113486A1 (ja) |
ZA (1) | ZA200610446B (ja) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060254029A1 (en) * | 2005-05-11 | 2006-11-16 | Conrad Swenson | Pocket loss prevention device |
NZ551288A (en) * | 2004-05-14 | 2010-10-29 | Janssen Pharmaceutica Nv | Carboxamido opioid compounds that are derivatives of tramadol |
BRPI0811639A2 (pt) * | 2007-05-31 | 2014-09-30 | Sepracor Inc | Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina |
JP5555890B2 (ja) * | 2009-03-19 | 2014-07-23 | アルカーメス ファーマ アイルランド リミテッド | 高い経口バイオアベイラビリティを有するモルフィナン誘導体 |
AU2010326676B2 (en) * | 2009-12-04 | 2013-03-14 | Alkermes Pharma Ireland Limited | Morphinan derivatives for the treatment of drug overdose |
HRP20240109T1 (hr) | 2010-08-23 | 2024-03-29 | Alkermes Pharma Ireland Limited | Postupci za liječenje povećanja tjelesne težine induciranog antipsihoticima |
US9029543B2 (en) | 2011-04-05 | 2015-05-12 | Alkermes, Inc. | Process for the synthesis of quaternary amine compounds |
US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
JP6038170B2 (ja) | 2011-12-15 | 2016-12-07 | アルカーメス ファーマ アイルランド リミテッド | ブプレノルフィンおよびμ−オピオイド受容体アンタゴニストの組成物 |
WO2014190270A1 (en) | 2013-05-24 | 2014-11-27 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
WO2014190271A2 (en) | 2013-05-24 | 2014-11-27 | Alkermes Pharma Ireland Limted | Methods for treating depressive symptoms |
CN104940709A (zh) * | 2015-07-22 | 2015-09-30 | 张秋英 | 一种镇痛麻醉喷雾剂 |
CN105055756A (zh) * | 2015-09-18 | 2015-11-18 | 张秋英 | 一种阴部挫伤用镇痛气雾剂 |
SG11201906430RA (en) | 2017-01-17 | 2019-08-27 | Mebias Discovery Inc | Substituted 3-dialkylaminomethyl-piperidin-4-yl-benzamides and methods of making and using same |
WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0507863A4 (en) * | 1989-12-28 | 1993-07-07 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
US6071970A (en) * | 1993-02-08 | 2000-06-06 | Nps Pharmaceuticals, Inc. | Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
DE4426245A1 (de) * | 1994-07-23 | 1996-02-22 | Gruenenthal Gmbh | 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung |
EP1353909B1 (en) * | 2000-10-31 | 2005-04-06 | Rensselaer Polytechnic Institute | 8-substituted-2,6-methano-3-benzazocines and 3-substituted morphinanes as opioidreceptor binding agents |
DE10059413A1 (de) * | 2000-11-30 | 2002-06-20 | Gruenenthal Gmbh | Verwendung von substituierten 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz |
DE10146275A1 (de) * | 2001-09-18 | 2003-04-24 | Gruenenthal Gmbh | Kombination ausgewählter Opioide mit Muscarin-Antagonisten zur Therapie der Harninkontinenz |
US6780891B2 (en) | 2001-11-30 | 2004-08-24 | Sepracor Inc. | Tramadol analogs and uses thereof |
DE10213051B4 (de) | 2002-03-23 | 2013-03-07 | Grünenthal GmbH | Substituierte 4-Aminocyclohexanole |
PT1594460E (pt) * | 2002-10-25 | 2008-06-27 | Labopharm Inc | Formulações de tramadol de libertação sustentada com eficácia durante 24 horas |
ES2367576T3 (es) | 2004-03-15 | 2011-11-04 | Janssen Pharmaceutica Nv | Nuevos compuestos como moduladores de receptores opioides. |
NZ551288A (en) * | 2004-05-14 | 2010-10-29 | Janssen Pharmaceutica Nv | Carboxamido opioid compounds that are derivatives of tramadol |
-
2005
- 2005-05-11 NZ NZ551288A patent/NZ551288A/en not_active IP Right Cessation
- 2005-05-11 AU AU2005245403A patent/AU2005245403B2/en not_active Ceased
- 2005-05-11 KR KR1020067026102A patent/KR101204751B1/ko active IP Right Grant
- 2005-05-11 EA EA200602115A patent/EA013261B1/ru not_active IP Right Cessation
- 2005-05-11 CA CA2566601A patent/CA2566601C/en not_active Expired - Fee Related
- 2005-05-11 WO PCT/US2005/016581 patent/WO2005113486A1/en active Application Filing
- 2005-05-11 CN CN2005800237355A patent/CN1984879B/zh not_active Expired - Fee Related
- 2005-05-11 MX MXPA06013270A patent/MXPA06013270A/es active IP Right Grant
- 2005-05-11 EP EP05757373.5A patent/EP1748978B1/en active Active
- 2005-05-11 BR BRPI0511137-4A patent/BRPI0511137A/pt not_active IP Right Cessation
- 2005-05-11 US US11/126,771 patent/US7244866B2/en active Active
- 2005-05-11 ES ES05757373.5T patent/ES2485867T3/es active Active
- 2005-05-11 JP JP2007513340A patent/JP5420170B2/ja not_active Expired - Fee Related
- 2005-05-13 TW TW094115467A patent/TWI418345B/zh not_active IP Right Cessation
- 2005-05-13 AR ARP050101970A patent/AR049276A1/es not_active Application Discontinuation
- 2005-11-05 UA UAA200612496A patent/UA90432C2/uk unknown
-
2006
- 2006-11-12 IL IL179196A patent/IL179196A/en not_active IP Right Cessation
- 2006-11-15 EC EC2006007008A patent/ECSP067008A/es unknown
- 2006-12-13 ZA ZA200610446A patent/ZA200610446B/en unknown
- 2006-12-13 CR CR8811A patent/CR8811A/es not_active Application Discontinuation
- 2006-12-14 NO NO20065768A patent/NO20065768L/no not_active Application Discontinuation
-
2007
- 2007-08-02 HK HK07108442.0A patent/HK1101246A1/xx not_active IP Right Cessation
-
2008
- 2008-07-30 US US12/182,462 patent/US7745492B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7745492B2 (en) | 2010-06-29 |
KR101204751B1 (ko) | 2012-11-27 |
US20050256203A1 (en) | 2005-11-17 |
NZ551288A (en) | 2010-10-29 |
JP2007537278A (ja) | 2007-12-20 |
AU2005245403B2 (en) | 2012-04-19 |
KR20070015613A (ko) | 2007-02-05 |
CA2566601A1 (en) | 2005-12-01 |
ECSP067008A (es) | 2006-12-29 |
IL179196A0 (en) | 2007-03-08 |
CN1984879A (zh) | 2007-06-20 |
TW200605871A (en) | 2006-02-16 |
HK1101246A1 (en) | 2007-10-12 |
CR8811A (es) | 2009-01-14 |
BRPI0511137A (pt) | 2007-11-27 |
US20080280990A1 (en) | 2008-11-13 |
WO2005113486A1 (en) | 2005-12-01 |
CA2566601C (en) | 2013-04-09 |
EP1748978A1 (en) | 2007-02-07 |
ZA200610446B (en) | 2008-07-30 |
UA90432C2 (uk) | 2010-04-26 |
AR049276A1 (es) | 2006-07-12 |
US7244866B2 (en) | 2007-07-17 |
EA013261B1 (ru) | 2010-04-30 |
AU2005245403A1 (en) | 2005-12-01 |
TWI418345B (zh) | 2013-12-11 |
EP1748978B1 (en) | 2014-06-04 |
EA200602115A1 (ru) | 2007-04-27 |
JP5420170B2 (ja) | 2014-02-19 |
ES2485867T3 (es) | 2014-08-14 |
MXPA06013270A (es) | 2007-04-23 |
CN1984879B (zh) | 2011-07-27 |
IL179196A (en) | 2012-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20065768L (no) | Karbonsamid-opioidforbindelser | |
NO20056130L (no) | Nye substituerte 3-svovelindoler | |
SE0203713D0 (sv) | Novel compounds | |
EA201071245A1 (ru) | Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс | |
UA87856C2 (ru) | Алкильные производные как модуляторы метаботропных рецепторов глутамата | |
IL178648A0 (en) | Substituted morpholine compounds for the treatment of central nervous system disorders | |
NO20061074L (no) | Forbindelser og sammensetninger som inbibitorer av reseptortyrosinkinaseaktivitet | |
WO2003096983A3 (en) | Method of treating dyslipidemic disorders | |
TW200407305A (en) | Novel compounds | |
TW200510303A (en) | Novel compounds | |
MY145070A (en) | Imidazolothiazole compounds for the treatment of disease | |
EA200970447A1 (ru) | Соединения и композиции в качестве ингибиторов протеинкиназы | |
DE602006013191D1 (de) | Substituierte 1h-benzimidazol-4-carbonsäureamide sind wirksame parp-inhibitoren | |
WO2007047447A3 (en) | Diuretic-like compound analogs useful for regulation of central nervous system disorders | |
WO2005081619A3 (en) | Compounds and methods for increasing neurogenesis | |
NO20070914L (no) | Fremgangsmater for behandling av nervesystemforstyrrelser og tilstander | |
WO2009105162A3 (en) | Hsp90 inhibitors or modulators for treatment or prevention of substance-related disorders | |
EA200602081A1 (ru) | Пиридиновые производные алкилоксиндолов в качестве агентов, активных в отношении рецептора 5-нт7 | |
WO2004047727A3 (en) | Compositions and methods for diagnosing and treating mood disorders | |
AU2003211040A8 (en) | The eaat2 promoter and uses thereof | |
AU2002347984A1 (en) | Use of norepinephrine reuptake inhibitors for the treatment of tic disorders | |
DE602004019698D1 (de) | Morpholinderivate als inhibitoren der wiederaufnahme von norepinephrin | |
ATE412634T1 (de) | Piperazinderivate von alkyloxindolen | |
UA85198C2 (ru) | Производные морфолина как ингибиторы повторного поглощения норэпинефрина | |
IL179030A0 (en) | Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |